Does 33895 require prior authorization?

No, 33895 does not require prior authorization (high confidence). Code is covered without prior authorization.

What is the Medicare reimbursement rate for 33895?

Medicare facility rate: $675.03. Non-facility rate: $675.03. Work RVU: 14.18.

HCPCS/CPT

No Prior Auth Required

Code is covered without prior authorization (high confidence)

Work RVU

14.18

Facility

$675.03

Non-Facility

$675.03

For aortic coarctation interventions: documentation of systemic arterial hypertension and resting arm–leg translesional pressure gradient >20 mm Hg (Hatoum et al, 2020; Rossi et al, 2020).
For TEVAR/complex repair when considering celiac artery coverage: documentation demonstrating adequate visceral collateral pathways prior to coverage (Argyriou et al, 2022).
For CSF drainage: documentation of rationale for pre-operative drain placement, procedural technical details of catheter insertion, target drainage pressure protocol (reported protocols commonly targeted intra-/post-operative pressures between 8 and 12 mm Hg), and monitoring/complication logs (Malloy et al, 2020; Suarez-Pierre et al, 2019).
Pre-procedure imaging and sizing: documentation of pre-procedure CT angiography (CTA) or other imaging used for "pre-procedure sizing and device selection" (codes descriptions repeatedly reference pre-procedure sizing and device selection).

Computed tomography (CT) surveillance after endovascular (stent) aortic repair at 1 month, 6 months, and 12 months following repair, then every year.
Endovascular repair of infra-renal abdominal aortic or aorto-iliac aneurysms with a Food and Drug Administration (FDA)-approved fenestrated, branched or non-fenestrated endovascular stent graft;
Endovascular repair of descending thoracic aortic aneurysms with an FDA-approved endoprosthesis;
Endovascular stenting (with a FDA-approved stent) for the treatment of aortic coarctation in persons with body weight of 25 kg (55 lbs) or more, and who exhibits systemic arterial hypertension and resting arm-leg pressure gradient of greater than 20 mmHg;
FEVAR indicated as an option for high-risk patients when open repair is not suitable (Rao et al, 2015; Ou et al, 2015).
FEVAR and chimney/endovascular (CH-EVAR) techniques as options for juxtarenal and short-neck AAAs (Li et al 2016; Ou et al 2015).

AETNA-CPB-0651 — Endovascular Repair of Aortic Diseases

Ask Verity about documentation requirements, denial risks, or coverage in your state.